OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer
Clinical trial NCT01802684 · COMPLETED
Trial details
- NCT number
- NCT01802684
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-11-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.